profits slide india dr reddy
profits indian drugmaker dr reddy fell costs rose sales flagged
firm profits rupees months december sales fell rupees dr reddy built reputation producing generic versions pharmaceutical products competition intensified firm company short product launches annoucement december won exclusive marketing rights generic version famous prozac maker eli lilly lost key court march banning selling version pfizer popular hypertension drug norvasc development drugs continuing apace spending rising rupees key decrease profits alongside fall sales patents products future representing opportunity dr reddy shares listed york indian generics manufacturers
sales dr reddy generics business fell rupees staple firm business sale ingredients drugs performed sales previous rupees strong competition europe dr reddy indian competitors gathering strength heavy competitive pressures
